Does BLOODCARE Powder Prevent Postoperative Chylous Ascites After Lymphadenectomy for Gynecological Malignancies?
OBJECTIVEThe aim of this study was to evaluate the effect of an intraoperative hemostatic cellulose agent (BLOODCARE powder [Life Line, Brno, Czech Republic]) on reducing the incidence of postoperative chylous ascites (PCA) after complete pelvic and para-aortic lymphadenectomy (PPALN) in patients wi...
Gespeichert in:
| Veröffentlicht in: | International journal of gynecological cancer 2017-11, Vol.27 (9), p.1979-1982 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1982 |
|---|---|
| container_issue | 9 |
| container_start_page | 1979 |
| container_title | International journal of gynecological cancer |
| container_volume | 27 |
| creator | Güngördük, Kemal Güngördük, Özgü Celikkol Ozdemir, I Aykut Gokcu, Mehmet Sanci, Muzaffer |
| description | OBJECTIVEThe aim of this study was to evaluate the effect of an intraoperative hemostatic cellulose agent (BLOODCARE powder [Life Line, Brno, Czech Republic]) on reducing the incidence of postoperative chylous ascites (PCA) after complete pelvic and para-aortic lymphadenectomy (PPALN) in patients with gynecological cancers treated with laparotomy.
METHODSThis case control study reviewed 150 patients with gynecological cancer who underwent PPALN. In the study group (n = 75), BLOODCARE powder was applied below the left renal vein and bilateral obturator fossa. In the control group (n = 75), no sealant agent was used after the procedure, such as fibrin glue or a hemostatic cellulose agent.
RESULTSThe demographic and surgical characteristics of the patients in both groups were similar. Chylous ascites occurred in 9 cases (6%). The incidence of PCA was lower in the study group (1 [1.3%] vs 8 [10.7%]; P = 0.03). Logistic regression analysis indicated that using BLOODCARE powder during the surgery independently protected against the development of PCA.
CONCLUSIONSUsing BLOODCARE powder during retroperitoneal surgery may prevent PCA. This simple, effective agent should be used after PPALN for gynecological cancers. |
| doi_str_mv | 10.1097/IGC.0000000000001093 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1925514766</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2579081420</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3843-605b150e3e1b96cd5a27b3a6eada1550b19d3641b3a6df4ba0307dc2f124f393</originalsourceid><addsrcrecordid>eNp9kU9P3DAQxa2qqFDKN6iqSL30Eur_iU_VEuiCtNWiikNvluNM2FAnXuyEVb59jRZQxQFf7Bn93tOMH0KfCT4lWBXfr5bVKf7vpCZ7h46IoCInnJXv0xvzMi8V-XOIPsZ4lyBFsfqADmlZSMakPEL35x5idrZar8-rxe-L7NrvGgjZdYAHGMZUxtFvIZixe4Cs2szOTzFbRNuNSbZox8Su5n67MQ0MYEffz1nrQ7acU-Wdv-2scdkv47rbwQy2g_jjEzpojYtw8nQfo5ufFzfVZb5aL6-qxSq3rOQsl1jURGBgQGolbSMMLWpmJJjGECFwTVTDJCePvabltcEMF42lLaG8ZYodo297223w9xPEUfddtOCcGSDtoImiQhBeSJnQr6_QOz-FIQ2nqSgULgmnOFF8T9ngYwzQ6m3oehNmTbB-TESnRPTrRJLsy5P5VPfQvIieI0hAuQd23qXvjH_dtIOgN2DcuHnb-x9QpZc3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2579081420</pqid></control><display><type>article</type><title>Does BLOODCARE Powder Prevent Postoperative Chylous Ascites After Lymphadenectomy for Gynecological Malignancies?</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Güngördük, Kemal ; Güngördük, Özgü Celikkol ; Ozdemir, I Aykut ; Gokcu, Mehmet ; Sanci, Muzaffer</creator><creatorcontrib>Güngördük, Kemal ; Güngördük, Özgü Celikkol ; Ozdemir, I Aykut ; Gokcu, Mehmet ; Sanci, Muzaffer</creatorcontrib><description>OBJECTIVEThe aim of this study was to evaluate the effect of an intraoperative hemostatic cellulose agent (BLOODCARE powder [Life Line, Brno, Czech Republic]) on reducing the incidence of postoperative chylous ascites (PCA) after complete pelvic and para-aortic lymphadenectomy (PPALN) in patients with gynecological cancers treated with laparotomy.
METHODSThis case control study reviewed 150 patients with gynecological cancer who underwent PPALN. In the study group (n = 75), BLOODCARE powder was applied below the left renal vein and bilateral obturator fossa. In the control group (n = 75), no sealant agent was used after the procedure, such as fibrin glue or a hemostatic cellulose agent.
RESULTSThe demographic and surgical characteristics of the patients in both groups were similar. Chylous ascites occurred in 9 cases (6%). The incidence of PCA was lower in the study group (1 [1.3%] vs 8 [10.7%]; P = 0.03). Logistic regression analysis indicated that using BLOODCARE powder during the surgery independently protected against the development of PCA.
CONCLUSIONSUsing BLOODCARE powder during retroperitoneal surgery may prevent PCA. This simple, effective agent should be used after PPALN for gynecological cancers.</description><identifier>ISSN: 1048-891X</identifier><identifier>EISSN: 1525-1438</identifier><identifier>DOI: 10.1097/IGC.0000000000001093</identifier><identifier>PMID: 28763366</identifier><language>eng</language><publisher>United States: by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology</publisher><subject>Ascites ; Case-Control Studies ; Cellulose ; Cellulose - administration & dosage ; Chylous Ascites - etiology ; Chylous Ascites - prevention & control ; Female ; Genital Neoplasms, Female - surgery ; Gynecological cancer ; Gynecology ; Hemostatics - administration & dosage ; Humans ; Lymph Node Excision - adverse effects ; Lymph Node Excision - methods ; Lymph Nodes - surgery ; Middle Aged ; Postoperative Complications - etiology ; Postoperative Complications - prevention & control ; Retrospective Studies</subject><ispartof>International journal of gynecological cancer, 2017-11, Vol.27 (9), p.1979-1982</ispartof><rights>2017 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.</rights><rights>2017 2017 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3843-605b150e3e1b96cd5a27b3a6eada1550b19d3641b3a6df4ba0307dc2f124f393</citedby><cites>FETCH-LOGICAL-c3843-605b150e3e1b96cd5a27b3a6eada1550b19d3641b3a6df4ba0307dc2f124f393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28763366$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Güngördük, Kemal</creatorcontrib><creatorcontrib>Güngördük, Özgü Celikkol</creatorcontrib><creatorcontrib>Ozdemir, I Aykut</creatorcontrib><creatorcontrib>Gokcu, Mehmet</creatorcontrib><creatorcontrib>Sanci, Muzaffer</creatorcontrib><title>Does BLOODCARE Powder Prevent Postoperative Chylous Ascites After Lymphadenectomy for Gynecological Malignancies?</title><title>International journal of gynecological cancer</title><addtitle>Int J Gynecol Cancer</addtitle><description>OBJECTIVEThe aim of this study was to evaluate the effect of an intraoperative hemostatic cellulose agent (BLOODCARE powder [Life Line, Brno, Czech Republic]) on reducing the incidence of postoperative chylous ascites (PCA) after complete pelvic and para-aortic lymphadenectomy (PPALN) in patients with gynecological cancers treated with laparotomy.
METHODSThis case control study reviewed 150 patients with gynecological cancer who underwent PPALN. In the study group (n = 75), BLOODCARE powder was applied below the left renal vein and bilateral obturator fossa. In the control group (n = 75), no sealant agent was used after the procedure, such as fibrin glue or a hemostatic cellulose agent.
RESULTSThe demographic and surgical characteristics of the patients in both groups were similar. Chylous ascites occurred in 9 cases (6%). The incidence of PCA was lower in the study group (1 [1.3%] vs 8 [10.7%]; P = 0.03). Logistic regression analysis indicated that using BLOODCARE powder during the surgery independently protected against the development of PCA.
CONCLUSIONSUsing BLOODCARE powder during retroperitoneal surgery may prevent PCA. This simple, effective agent should be used after PPALN for gynecological cancers.</description><subject>Ascites</subject><subject>Case-Control Studies</subject><subject>Cellulose</subject><subject>Cellulose - administration & dosage</subject><subject>Chylous Ascites - etiology</subject><subject>Chylous Ascites - prevention & control</subject><subject>Female</subject><subject>Genital Neoplasms, Female - surgery</subject><subject>Gynecological cancer</subject><subject>Gynecology</subject><subject>Hemostatics - administration & dosage</subject><subject>Humans</subject><subject>Lymph Node Excision - adverse effects</subject><subject>Lymph Node Excision - methods</subject><subject>Lymph Nodes - surgery</subject><subject>Middle Aged</subject><subject>Postoperative Complications - etiology</subject><subject>Postoperative Complications - prevention & control</subject><subject>Retrospective Studies</subject><issn>1048-891X</issn><issn>1525-1438</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kU9P3DAQxa2qqFDKN6iqSL30Eur_iU_VEuiCtNWiikNvluNM2FAnXuyEVb59jRZQxQFf7Bn93tOMH0KfCT4lWBXfr5bVKf7vpCZ7h46IoCInnJXv0xvzMi8V-XOIPsZ4lyBFsfqADmlZSMakPEL35x5idrZar8-rxe-L7NrvGgjZdYAHGMZUxtFvIZixe4Cs2szOTzFbRNuNSbZox8Su5n67MQ0MYEffz1nrQ7acU-Wdv-2scdkv47rbwQy2g_jjEzpojYtw8nQfo5ufFzfVZb5aL6-qxSq3rOQsl1jURGBgQGolbSMMLWpmJJjGECFwTVTDJCePvabltcEMF42lLaG8ZYodo297223w9xPEUfddtOCcGSDtoImiQhBeSJnQr6_QOz-FIQ2nqSgULgmnOFF8T9ngYwzQ6m3oehNmTbB-TESnRPTrRJLsy5P5VPfQvIieI0hAuQd23qXvjH_dtIOgN2DcuHnb-x9QpZc3</recordid><startdate>201711</startdate><enddate>201711</enddate><creator>Güngördük, Kemal</creator><creator>Güngördük, Özgü Celikkol</creator><creator>Ozdemir, I Aykut</creator><creator>Gokcu, Mehmet</creator><creator>Sanci, Muzaffer</creator><general>by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>201711</creationdate><title>Does BLOODCARE Powder Prevent Postoperative Chylous Ascites After Lymphadenectomy for Gynecological Malignancies?</title><author>Güngördük, Kemal ; Güngördük, Özgü Celikkol ; Ozdemir, I Aykut ; Gokcu, Mehmet ; Sanci, Muzaffer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3843-605b150e3e1b96cd5a27b3a6eada1550b19d3641b3a6df4ba0307dc2f124f393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Ascites</topic><topic>Case-Control Studies</topic><topic>Cellulose</topic><topic>Cellulose - administration & dosage</topic><topic>Chylous Ascites - etiology</topic><topic>Chylous Ascites - prevention & control</topic><topic>Female</topic><topic>Genital Neoplasms, Female - surgery</topic><topic>Gynecological cancer</topic><topic>Gynecology</topic><topic>Hemostatics - administration & dosage</topic><topic>Humans</topic><topic>Lymph Node Excision - adverse effects</topic><topic>Lymph Node Excision - methods</topic><topic>Lymph Nodes - surgery</topic><topic>Middle Aged</topic><topic>Postoperative Complications - etiology</topic><topic>Postoperative Complications - prevention & control</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Güngördük, Kemal</creatorcontrib><creatorcontrib>Güngördük, Özgü Celikkol</creatorcontrib><creatorcontrib>Ozdemir, I Aykut</creatorcontrib><creatorcontrib>Gokcu, Mehmet</creatorcontrib><creatorcontrib>Sanci, Muzaffer</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of gynecological cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Güngördük, Kemal</au><au>Güngördük, Özgü Celikkol</au><au>Ozdemir, I Aykut</au><au>Gokcu, Mehmet</au><au>Sanci, Muzaffer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does BLOODCARE Powder Prevent Postoperative Chylous Ascites After Lymphadenectomy for Gynecological Malignancies?</atitle><jtitle>International journal of gynecological cancer</jtitle><addtitle>Int J Gynecol Cancer</addtitle><date>2017-11</date><risdate>2017</risdate><volume>27</volume><issue>9</issue><spage>1979</spage><epage>1982</epage><pages>1979-1982</pages><issn>1048-891X</issn><eissn>1525-1438</eissn><abstract>OBJECTIVEThe aim of this study was to evaluate the effect of an intraoperative hemostatic cellulose agent (BLOODCARE powder [Life Line, Brno, Czech Republic]) on reducing the incidence of postoperative chylous ascites (PCA) after complete pelvic and para-aortic lymphadenectomy (PPALN) in patients with gynecological cancers treated with laparotomy.
METHODSThis case control study reviewed 150 patients with gynecological cancer who underwent PPALN. In the study group (n = 75), BLOODCARE powder was applied below the left renal vein and bilateral obturator fossa. In the control group (n = 75), no sealant agent was used after the procedure, such as fibrin glue or a hemostatic cellulose agent.
RESULTSThe demographic and surgical characteristics of the patients in both groups were similar. Chylous ascites occurred in 9 cases (6%). The incidence of PCA was lower in the study group (1 [1.3%] vs 8 [10.7%]; P = 0.03). Logistic regression analysis indicated that using BLOODCARE powder during the surgery independently protected against the development of PCA.
CONCLUSIONSUsing BLOODCARE powder during retroperitoneal surgery may prevent PCA. This simple, effective agent should be used after PPALN for gynecological cancers.</abstract><cop>United States</cop><pub>by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology</pub><pmid>28763366</pmid><doi>10.1097/IGC.0000000000001093</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1048-891X |
| ispartof | International journal of gynecological cancer, 2017-11, Vol.27 (9), p.1979-1982 |
| issn | 1048-891X 1525-1438 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1925514766 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Ascites Case-Control Studies Cellulose Cellulose - administration & dosage Chylous Ascites - etiology Chylous Ascites - prevention & control Female Genital Neoplasms, Female - surgery Gynecological cancer Gynecology Hemostatics - administration & dosage Humans Lymph Node Excision - adverse effects Lymph Node Excision - methods Lymph Nodes - surgery Middle Aged Postoperative Complications - etiology Postoperative Complications - prevention & control Retrospective Studies |
| title | Does BLOODCARE Powder Prevent Postoperative Chylous Ascites After Lymphadenectomy for Gynecological Malignancies? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T11%3A35%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20BLOODCARE%20Powder%20Prevent%20Postoperative%20Chylous%20Ascites%20After%20Lymphadenectomy%20for%20Gynecological%20Malignancies?&rft.jtitle=International%20journal%20of%20gynecological%20cancer&rft.au=G%C3%BCng%C3%B6rd%C3%BCk,%20Kemal&rft.date=2017-11&rft.volume=27&rft.issue=9&rft.spage=1979&rft.epage=1982&rft.pages=1979-1982&rft.issn=1048-891X&rft.eissn=1525-1438&rft_id=info:doi/10.1097/IGC.0000000000001093&rft_dat=%3Cproquest_cross%3E2579081420%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2579081420&rft_id=info:pmid/28763366&rfr_iscdi=true |